Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1259811.RAWZodhvXrp4o3PpQXDZ6eg3ki3R2r5zCVrgYoAZKWBRY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1259811.RAWZodhvXrp4o3PpQXDZ6eg3ki3R2r5zCVrgYoAZKWBRY130_assertion type Assertion NP1259811.RAWZodhvXrp4o3PpQXDZ6eg3ki3R2r5zCVrgYoAZKWBRY130_head.
- NP1259811.RAWZodhvXrp4o3PpQXDZ6eg3ki3R2r5zCVrgYoAZKWBRY130_assertion description "[In bladder cancer cell lines, cyclosporine A (CsA) and tacrolimus (FK506), immunosuppressant drugs/non-selective NFAT inhibitors, attenuated NFATc1 expression and its nuclear translocation, NFAT transcriptional activity, and the expression of cyclooxygenase-2 and c-myc, downstream targets of NFATc1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1259811.RAWZodhvXrp4o3PpQXDZ6eg3ki3R2r5zCVrgYoAZKWBRY130_provenance.
- NP1259811.RAWZodhvXrp4o3PpQXDZ6eg3ki3R2r5zCVrgYoAZKWBRY130_assertion evidence source_evidence_literature NP1259811.RAWZodhvXrp4o3PpQXDZ6eg3ki3R2r5zCVrgYoAZKWBRY130_provenance.
- NP1259811.RAWZodhvXrp4o3PpQXDZ6eg3ki3R2r5zCVrgYoAZKWBRY130_assertion SIO_000772 25638160 NP1259811.RAWZodhvXrp4o3PpQXDZ6eg3ki3R2r5zCVrgYoAZKWBRY130_provenance.
- NP1259811.RAWZodhvXrp4o3PpQXDZ6eg3ki3R2r5zCVrgYoAZKWBRY130_assertion wasDerivedFrom befree-2016 NP1259811.RAWZodhvXrp4o3PpQXDZ6eg3ki3R2r5zCVrgYoAZKWBRY130_provenance.
- NP1259811.RAWZodhvXrp4o3PpQXDZ6eg3ki3R2r5zCVrgYoAZKWBRY130_assertion wasGeneratedBy ECO_0000203 NP1259811.RAWZodhvXrp4o3PpQXDZ6eg3ki3R2r5zCVrgYoAZKWBRY130_provenance.